BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 5068243)

  • 1. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
    Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
    Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y; Takeda K; Otorii T; Horii D; Imai S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of a trimethoxybenzoic acid derivative on the coronary circulation in the human].
    Behrenbeck DW; Wagner J; Hellwig H; Grenzmann M; Hilger HH
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():287-92. PubMed ID: 5736278
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic aspects of reactions of the cardiac circulation to drugs].
    Zakusov VV
    Vestn Akad Med Nauk SSSR; 1963; 18(1):3-9. PubMed ID: 5889334
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
    Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
    Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies of 3-(3,3-diphenylpropylamino)-propyl-3',4',5'-trimethoxybenzoate (PF-26), a new coronary vasodilator.
    Hatano N; Sohji Y; Kawashima K; Kaneko H
    Arzneimittelforschung; 1971 Nov; 21(11):1628-33. PubMed ID: 5172070
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nerobol on blood supply of the heart, contraction ability of the myocardium and hemodynamic condition].
    Seliverstov SA
    Farmakol Toksikol; 1969; 32(2):159-62. PubMed ID: 5772139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influencing of the circulation rate and oxygen metabolism in the ischemic myocardium. Comparison with the effect on the normal myocardium].
    Parrat JR; Marshall RJ; Ledingham IM
    Med Welt; 1974 Jul; 25(26):1152-5. PubMed ID: 4152465
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Simultaneous comparison with changes in the normal myocardium.
    Marshall RJ; Parratt JR
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):427-36. PubMed ID: 4275262
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 1st communication: effects on myocardium and vasculature.
    Hirata Y; Suzuki Y; Miyai H; Aisaka K
    Arzneimittelforschung; 2000 Mar; 50(3):236-43. PubMed ID: 10758774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.